• About Us
  • Contact Us
  • Disclaimer
  • Privacy Policy
Friday, August 12, 2022
No Result
View All Result
  • Login
Rajesh Spinal Cord Injury
  • Home
  • Spinal Cord Injury
  • Rehabilitation
    •  Epidural Stimulation
  • Latest SCI News
  • Spine
  • Neuro
  • Health
  • Ayurveda
  • More
    • Diet-Nutrition
    • Healthy Recipes
    • Nutrition Supplements
    • Weight Loss
    • Yoga & Meditation
  • Home
  • Spinal Cord Injury
  • Rehabilitation
    •  Epidural Stimulation
  • Latest SCI News
  • Spine
  • Neuro
  • Health
  • Ayurveda
  • More
    • Diet-Nutrition
    • Healthy Recipes
    • Nutrition Supplements
    • Weight Loss
    • Yoga & Meditation
HealthNews
No Result
View All Result
Home Spine

BioRestorative Therapies Pronounces the Appointment of Robert Paccasassi to Vice President of High quality Assurance/Regulatory Compliance

admin by admin
January 21, 2022
in Spine
0
BioRestorative Therapies Pronounces the Appointment of Robert Paccasassi to Vice President of High quality Assurance/Regulatory Compliance


MELVILLE, N.Y., Jan. 11, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Firm” or “BioRestorative”) (NASDAQ:BRTX), a life sciences firm centered on stem cell-based therapies, in the present day introduced that Robert Paccasassi has been appointed Vice President of High quality Assurance/Regulatory Compliance. Mr. Paccasassi will lead high quality initiatives by the subsequent section of the Firm’s development as affected person enrollment is initiated for the Part 2 scientific trial to deal with persistent lumbar disc illness.

Mr. Paccasassi has over 25 years of biotech operations and mixed expertise in High quality Assurance, Regulatory Compliance, and Manufacturing. Previous to becoming a member of BioRestorative, Mr. Paccasassi held the position of Director, Company High quality Techniques (GMP) at Merck KGaA (Germany). Moreover, he additionally held High quality and Compliance roles at Regeneron Prescription drugs, Millennium Prescription drugs and Biogen Idec.. Mr. Paccasassi obtained his B.S. in Medical Expertise/Biology from the College of Rhode Island and an MBA from Johnson and Wales College.

Mr. Paccasassi can be chargeable for BioRestorative’s cGMP High quality Management and Regulatory Compliance operations as they relate to the Firm’s product pipeline.

“We’re lucky to have Bob in a management position overseeing our high quality and compliance actions.” stated Lance Alstodt, CEO of BioRestorative. “Bob brings quite a lot of experience to the group, offering capabilities and self-discipline to our already sturdy high quality techniques.”

About BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc. (www.biorestorative.com) develops therapeutic merchandise utilizing cell and tissue protocols, primarily involving grownup stem cells. Our two core packages, as described under, relate to the therapy of disc/backbone illness and metabolic problems:

• Disc/Backbone Program (brtxDISC™): Our lead cell remedy candidate, BRTX-100, is a product formulated from autologous (or an individual’s personal) cultured mesenchymal stem cells collected from the affected person’s bone marrow. We intend that the product can be used for the non-surgical therapy of painful lumbosacral disc problems or as a complementary therapeutic to a surgical process. The BRTX-100 manufacturing course of makes use of proprietary know-how and includes amassing a affected person’s bone marrow, isolating and culturing stem cells from the bone marrow and cryopreserving the cells. In an outpatient process, BRTX-100 is to be injected by a doctor into the affected person’s broken disc. The therapy is meant for sufferers whose ache has not been alleviated by non-invasive procedures and who doubtlessly face the prospect of surgical procedure. Now we have obtained authorization from the Food and Drug Administration to begin a Part 2 scientific trial utilizing BRTX-100 to deal with persistent decrease again ache arising from degenerative disc illness.

• Metabolic Program (ThermoStem®): We’re growing a cell-based remedy candidate to focus on weight problems and metabolic problems utilizing brown adipose (fats) derived stem cells to generate brown adipose tissue (“BAT”). BAT is meant to imitate naturally occurring brown adipose depots that regulate metabolic homeostasis in people. Preliminary preclinical analysis signifies that elevated quantities of brown fats in animals could also be chargeable for extra caloric burning in addition to lowered glucose and lipid ranges. Researchers have discovered that individuals with greater ranges of brown fats could have a lowered threat for weight problems and diabetes. 

Ahead-Wanting Statements

This press launch comprises “forward-looking statements” throughout the which means of Part 27A of the Securities Act of 1933, as amended, and Part 21E of the Securities Alternate Act of 1934, as amended, and such forward-looking statements are made pursuant to the secure harbor provisions of the Personal Securities Litigation Reform Act of 1995. You might be cautioned that such statements are topic to a mess of dangers and uncertainties that might trigger future circumstances, occasions or outcomes to vary materially from these projected within the forward-looking statements on account of numerous components and different dangers, together with, with out limitation, these set forth within the Firm’s newest Kind 10-Ok filed with the Securities and Alternate Fee. You need to think about these components in evaluating the forward-looking statements included herein, and never place undue reliance on such statements. The forward-looking statements on this launch are made as of the date hereof and the Firm undertakes no obligation to replace such statements.

CONTACT:

E mail: ir@biorestorative.com

Share via:

0 Shares
  • Facebook 0
  • Twitter
  • Email
  • Copy Link
  • More
ShareTweetSendShare
Previous Post

Lunch line vs. lunch field | Health Beat

Next Post

Leucorrhoea Therapy in Ayurveda | Bodywise

admin

admin

Related Posts

Dr. Sean McCance, Top NYC Spine Surgeon, Recognized as a 2022 Castle Connolly Top Doctor®
Spine

Dr. Sean McCance, Top NYC Spine Surgeon, Recognized as a 2022 Castle Connolly Top Doctor®

August 12, 2022
Zavation releases In-Vitro and In-Vivo Research Summary for its novel “LABYRINTH™”
Spine

Zavation releases In-Vitro and In-Vivo Research Summary for its novel “LABYRINTH™”

August 10, 2022
NuVasive Opens Singapore Experience Center for Asia-Pacific region
Spine

NuVasive Announces Departure of Chief Commercial Officer

August 10, 2022
AxioMed LLC Submits Final Module III to the FDA Becoming the First and Only Lumbar Viscoelastic Total Disc Replacement Company to Complete a USA IDE Clinical Trial
Spine

AxioMed LLC Submits Final Module III to the FDA Becoming the First and Only Lumbar Viscoelastic Total Disc Replacement Company to Complete a USA IDE Clinical Trial

August 10, 2022
Avail Reaches Significant Network Expansion Milestone with the Signing of its 50th MedTech Contract
Spine

Avail Reaches Significant Network Expansion Milestone with the Signing of its 50th MedTech Contract

August 5, 2022
Spine Surgery is the Gateway to the New OR Ecosystem: Can We Step Up?
Spine

Spine Surgery is the Gateway to the New OR Ecosystem: Can We Step Up?

August 4, 2022
Load More
Next Post
Leucorrhoea Therapy in Ayurveda | Bodywise

Leucorrhoea Therapy in Ayurveda | Bodywise

Discussion about this post

Recent News

Shocking Ashwagandha Side Effects that Everyone Should Know!

Shocking Ashwagandha Side Effects that Everyone Should Know!

August 12, 2022
Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

August 12, 2022
Wash. jury sides with Issaquah officers accused of excessive force that killed an Alzheimer’s patient

Wash. jury sides with Issaquah officers accused of excessive force that killed an Alzheimer’s patient

August 12, 2022
Spinal Cord Injury Pipeline: Insights, Emerging Therapies, Key

Spinal Cord Injury Pipeline: Insights, Emerging Therapies, Key

August 12, 2022

About


Rajeshspinalinjury.com is the latest “Spinal Cord Injury, Neuro, and Health” NEWS website. We’ll provide you with merely interesting content. 

Categories

  • Ayurveda
  • Diet & Nutrition
  • Health News
  • Healthy Recipes
  • Neuro
  • Nutrition Supplements
  • Spinal Cord Injury News
  • Spine
  • Weight Loss
  • Yoga & Meditation
No Result
View All Result

Recent News

Shocking Ashwagandha Side Effects that Everyone Should Know!

Shocking Ashwagandha Side Effects that Everyone Should Know!

August 12, 2022
Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

August 12, 2022
  • About Us
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Terms of Condition

Rajeshspinalinjury © 2022 || All Right Reserved. Design by Rinku

No Result
View All Result
  • Home
  • Spinal Cord Injury
  •  Epidural Stimulation
  • Rehabilitation
  • Spinal Cord Injury News
  • Spine
  • Neuro
  • Ayurveda
  • Diet & Nutrition
  • Health News
    • Healthy Recipes
  • Nutrition Supplements
  • Yoga & Meditation
  • Weight Loss
  • About Us
  • Contact Us

Rajeshspinalinjury © 2022 || All Right Reserved. Design by Rinku

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
  • Facebook
  • Twitter
  • Email
  • Copy Link
  • More Networks
Share via
Facebook
Twitter
LinkedIn
Mix
Email
Print
Copy Link
Powered by Social Snap
Copy link
CopyCopied
Powered by Social Snap